Actuate Therapeutics Statistics
NASDAQ: ACTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.6593-0.0649 (-8.96%)
Market open · Delayed 15 min · as of Oct 8, 10:10 AM ET
Actuate Therapeutics by the numbers
Actuate Therapeutics has a market capitalization of $15.8 million based on 24.01M shares outstanding. With trailing EPS of $-0.87, Actuate Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.7% below its 50-day average and 75.1% below its 200-day average.
Average daily trading volume is 391.80K shares, or about $258,316 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACTU valuation vs. peer median
| Metric | ACTU | Peer median | Difference |
|---|---|---|---|
| Market cap | $15.83M | $16.52M | -4% |
| Avg. volume | 391.80K | 87.63K | +347% |
Peer median across 8 companies: MRKR, RADX, NCEL, PTN, NEUP, RKTO, ALLR, LPCN.
Valuation
- Market cap
- $15.83M
- EPS (TTM)
- $-0.87
- Shares outstanding
- 24.01M
Price and trading
- Previous close
- 0.7242
- Open
- 0.6822
- Day range
- 0.633 – 0.6846
- 52-week range
- 0.604 – 8.49
- 52-week change
- -89.71%
- Beta
- —
- Volume
- 61.83K
- Average volume
- 391.80K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 15.83M
- Forward Pe
- -0.99
- Eps
- -0.87
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.49
- Week52 Low
- 0.60
- Avg Volume
- 391.80K
- Shares Outstanding
- 24.01M
- Ma50
- 1.09
- Ma200
- 2.64
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -92.23%
- Pct From52w Low
- 9.16%